1 1 Andrew Harrison, CEO Benjamin Carruthers, CFO FY26 Full - Year Results August 28 th 2026 01 Why Resonance & Highlights Why Resonance - Why Now & FY26 Highlights ASX : RHT I N T H I S S E C T I O N 3 The Business 4 5 Why Resonance – Why Now 6 FY26 Highlights 2 Global...
FY26 Full Year Results & FY27 Guidance Investor Presentation
Filed with ASX · · 35 pages · English
Summary by 6ix AI
Resonance Health Ltd has released its full-year results for the fiscal year, highlighting significant revenue growth and a return to profitability. The company reported a notable increase in revenue and normalised EBITDA, reflecting strong operational performance across its three business segments.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
In the deck
Story so far
Earlier from Resonance Health
- Appendix 4E, Full Year Statutory Accounts & Annual Report
- FY26 Full Year Results Webinar
- Cessation of Quarterly Reporting
- Liver Fibrosis Device Progress & FY26 Portfolio Webinar
- Profit Guidance Upgrade
Later from Resonance Health
- FY26 Full Year Results & Investor Webinar
- Appendix 4G & Corporate Governance Statement
- Global Strategic Alliance & MSA with Image Analysis Group
- Change in Substantial Holding
- AGM Date & Director Nomination Closing Date
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health